REFERENCIAS

1. Leibowitz S, Greenwald L, Cohen I, Litwins J. Serum hepatitis in a blood bank worker. JAMA 1949;140:1331-3.
2. Byrne EB. Viral hepatitis: an occupational hazard of medical personnel. Experience of the Yale-New Haven Hospital, 1952 to 1965. JAMA 1966;195:362-4.
3. Williams SV, Huff JC, Feinglass EJ, Gregg MB, Hatch MH, Matsen JM. Epidemic viral hepatitis, type B, in hospital personnel. Am J Med 1974;57:904-11.
4. Hadler SC, Doto IL, Maynard JE, Smith J, Clark B, Mosley J, Eickhoff T, Himmelsbach CK, Cole WR. Occupational risk for hepatitis B infection in hospital workers. Infect Control 1985;6:24-31.
5. Gerberding JL. The infected health care provider. N Eng J Med 1996;334:594-5.
6. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and citomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. J Infect Dis 1994;170:1410-7.
7. MastEE, Alter MJ. Prevention of hepatitis B virus infection among health care workers. En: Ellis RW, ed. Hepatitis B Vaccines in Clinical Practice. New York: Marcel Dekker; 1993:295-307.
8. Grady GF, Kane MA. Hepatitis B infections accounts for multi-million dollar loss. Hosp Infect Control 1981;8:60-2.
9. Gibas A, Blewett DR, Schoenfeld DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis vaccination era. Am J Epidemiol 1992;136:603-10.
10. Bussalleu A, Cieza J, ColichOn A, Berrios J. Prevalencia de hepatitis viral tipo B en pacientes y personal de tres unidades de hemodiálisis en Lima. Rev Med Hered 1991;4:160-7.
11. Snydman DR, MuÑoz A, Werner BG, Polk BF, Craven DE, Platt R, Crumpacker C, Ouellet-Hellstrom R, Nash B, Grady GF, et al. A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. Am J Epidemiol 1984;120:684-93.
12. Deville J, Llanos A, Campos M, Philips I, Gotuzzo E, Kilpatrick M. Factores de riesgo para infección por virus de hepatitis en personal hospitalario. Rev Gastroent Peru 1989;9:24-8.
13. Huertas MA, Rivera-Morales IM, Romero C, Ponce de León S. Accidentes laborales e incidencia de infección por VIH y hepatitis B y C en una institución mexicana. Rev Invest Clin 1995;47:181-7.
14. Hepatitis Vírica B. En: El control de las enfermedades transmisibles en el hombre: Informe de la Asociación Estadounidense de Salud Pública. Benenson AS, ed. 15ª ed. Washington, D.C.: OPS, 1992:266-74.
15. Torres JR, Machado IV. Special aspects of hepatitis B virus and delta virus infection in Latin America. Infect Dis Clin North Am 1994;8:13-27.
16. Torres JR. Hepatitis B and hepatitis delta virus infection in South America. Gut 1996;38(suppl 2):s48-s55.
17. Cabezas C. Epidemiología de las hepatitis virales B y delta en el Perú. Rev Med Exp INS 1997;XIV:57-62.
18. West DJ. The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci 1984;287:26-33.
19. Osterholm MT, Garayalde SM. Clinical viral hepatitis B among Minnesota hospital personnel: results of a ten-year statewide survey. JAMA 1985;254:3207-12. 
20. Janzen J, Tripatzis I, Wagner U, Schlieter M, Muller-Dethard E, Wolters E. Epidemiology of hepatitis B surface antigen (HBsAg) and antibody to HBsAg in hospital personnel. J Infect Dis 1978;137:261-5.
21. Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol 1982;115:26-39.
22. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, Mares A, Miller JK, Moyer LA. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990;263:1218-22.
23. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997;157:2601-5. 
24. Lanphear BP, Linnemann CC Jr, Cannon CG, DeRonde MM. Decline of clinical hepatitis B in workers at a general hospital: relation to increasing vaccine-induced immunity. Clin Infect Dis 1993;16:10-4. 
25. Christenson B. Acute infections with hepatitis B virus in medical personnel during a 15-year follow-up. Am J Epidemiol 1985;122:411-7. 
26. Stroffolini T, Palumbo F, Galanti C, Moiraghi A, Novaco F, Corona R, Marzolini A, Mele A. Hepatitis B in health workers in Italy. Public Health 1994;108:433-7. 
27. Ohara H, Ebisawa I, Naruto H. Prophylaxis of acute viral hepatitis by immune serum globulin, hepatitis B vaccine, and health education: A sixteen year study of Japan Overseas Cooperation Volunteers. Am J Trop Med Hyg 1997;56:76-9. 
28. Vildósola H, Colichón A, Bardales F, Serván J. Prevalencia de marcadores serológicos de hepatitis B en personal de salud y administrativo de un hospital general de la selva del Perú. Rev Gastroent Peru 1989;9:77-82.
29. Del Aguila A, Rojas P. Determinación de la prevalencia de marcadores séricos del virus de la hepatitis B en pacientes tratados en la Clínica Estomatológica de la Universidad Peruana Cayetano Heredia. Rev Estomatol Herediana 1992;2:28-32.
30. Kalish SB, Fisher B, Wallemark CB, Chmiel JS, Phair JP. Prevalence of antibody to hepatitis B virus in foreign-born hospital employees. Am J Med 1987;83:824-8.
31. Mejía P. Exposición ocupacional al virus de la hepatitis B del personal hospitalario del Centro Médico Naval «Cirujano Mayor Santiago Távara». Rev Gastroent Peru 1993;13:20-7.
32. Robinson WS. Hepatitis B virus and hepatitis delta virus. En: Principles and practice of infectious diseases. Mandell GL, Douglas RG Jr, Bennett JE, eds. 3ra ed. New York: Churchill Livingstone, 1990:1204-31.
33. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Eng J Med 1995;332:444-51.
34. Werner BG, Grady GF. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med 1982;97:367-9.
35. Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, Schmidt PJ. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med 1972;77:691-9.
36. Jenison SA, Lemon SM, Baker LN, Newbold JE. Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J Infect Dis 1987;156:299-307.
37. Villarejos VM, Visoná KA, Gutiérrez A, Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Eng J Med 1974;291:1375-8.
38. Lack of transmission of hepatitis B to humans after oral e xposure to hepatitis B surface antigen-positive saliva. MMWR Morb Mortal Wkly Rep 1978;27:247-8.
39. Petersen NJ. An assessment of the air borne route in hepatitis B transmission. N Y Acad Sci 1980;353:157-66.
40. Cabezas C, Anaya E, Bartalesi F, Sánchez J. Transmisión horizontal de hepatitis viral B en población desplazada de un área hiperendémica a sus contactos en un área de baja endemicidad del Perú. Rev Gastroent Perú 1997;17:128-34.
41. Ju H, Lai C, Yiu-Nam J, Chung H, Lauder IJ, Fong M. Evidence for intrafamilial transmission of hepatitis B virus from sequence analysis of mutant HBV DNAs in two Chinese families. Lancet 1990,336:208-12. 
42. Peters CJ, Purcell RH, Lander JJ, Jhonson KM. Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B virus among household contacts. J Infect Dis 1976;134:218-23.
43. Vernon TM, Wright RA, Kohler PF, Merrill DA. Hepatitits A and B in the family unit: nonparenteral transmission by asyntomatic children. JAMA 1976;235:2829-31.
44. Bell DM, Shapiro CN, Gooch BF. Preventing HIV transmission to patients during invasive procedures. J Public Health Dent 1993;53:170-3.
45. The Incident Investigation Teams and Others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Eng J Med 1997;336:178-84.
46. Harpaz R, Von Seidlein, Averhoff FM, Tormey MP, Sinha SD, Kotsopoulou K, Lambert SB, Robertson BH, Cherry JD, Shapiro CN. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Eng J Med 1996;334:549-54. 
47. Ristinen E, Mamtani R. Ethics on transmission of hepatitis B virus by health-care workers. Lancet 1998;352:1381-3.
48. Doebbeling BN, Wenzel RP. Nosocomial viral hepatitis and infections transmitted by blood and blood products. En: Principles and practice of infectious diseases. Mandell GL, Douglas RG Jr, Bennett JE, eds. 3ra ed. New York: Churchill Livingstone, 1995.
49. Fenner F. Candidate viral diseases for elimination or erradication. Bull World Health Organ 1998,76(Suppl. 2):68-70.
50. Losos J. Report of the Workgroup on viral diseases. Bull World Health Organ 1998,76(Suppl. 2):94-102.
51. Margolis HS. Hepatitis B virus infection. Bull World Health Organ 1998,76(Suppl. 2):152-3.
52. Cabezas C, Ramos F, Vega M, Suárez M, Romero G, Carrillo C, Strull M, Reyna M, García MP, Gotuzzo E. Impacto del programa de vacunación contra hepatitis viral B (HVB) integrado al programa ampliado de inmunizaciones (PAI) en Huanta (Perú) 1994-1997. Rev Gastroent Peru 2000;20:201-12.
53. Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986;153:1149-51.
54. Fernández R, Rivero D, Echevarría B, Machado I. Costo-beneficio de la vacunación contra la hepatitis B en trabajadores de hospitales de Venezuela. Bol Of Sanit Panam 1991;111:16-23.
55. Gomez ML, de Oliveira PM, Figueiredo VM, Kemp VL, Castelo Filho A, Silva AE. Optimizacao do emprego de recursos economicos para vacinacao contra hepatite B em profissionais da área de saúde. Rev Soc Bras Med Trop 1995;28:393-403.
56. Chu G, García L. Evaluación de la protección de los trabajadores de un hospital del IPSS con vacuna DNA recombinante contra el virus de la hepatitis B. Boletín Sociedad Peruana de Medicina Interna 1998;11:126-30.
57. Zumaeta E, Figueroa R, Ferrándiz J, Gonzáles A, Ramírez V. Vacuna recombinante contra la hepatitis viral B en trabajadores de la salud del Instituto Peruano de la Seguridad Social. Rev Gastroent Peru 1995;15:135-9.
58. Roome AJ, Walsh SJ, Carter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993;270:2931-4.
59. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care orkers. JAMA 1993;270:2935-9.
60. Protections against viral heatitis. Recommendatios of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1990;39(RR-2):1-26.
61. Owens DK, Neaser RF Jr. Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk. Am J Med 1992;92:503-12.
62. Zuckerman AJ. Occupational exposure to hepatitis B virus and human immunodeficiency virus: a comparative risk analysis. Am J Infect Control 1995;23:286-9.
63. Denes AE, Smith JL, Maynard JE, Doto IL, Berquist KR, Finkel AJ. Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA 1978;239:210-2.
64. Occupational Safety and Health Administration. Occupational exposure to bloodborne patthogens-final rule. Fed Reg 1991;56(235):64004-182.
65. Goh KT, Oon CJ, Heng BH, Lim GK. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull World Health Organ 1995;73:523-7.
66. Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P. Randomized placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units, I: medical staff. Lancet 1981;1:455-459.
67. Milne A, Waldon J. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster dose at 51/2 years. J Infect Dis 1992;166:942.
68. Horowitz MM, Ershler WB, McKinney WP, Battiola RJ. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. Ann Intern Med 1988;108:185-9.
69. Nowicki MJ, Tong MJ, Bohman RE. Alterations in the immune response of nonresponders to hepatitis B vaccine. J Infect Dis 1985;152:1245-8.
70. Rumi M, Colombo M, Romeo R, Boschini A, Zanetti A, Gringeri A, Mannucci PM. Suboptimal response to hepatitis B vaccine in drug users. Arch Intern Med 1991;151:574-8.
71. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Commitee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40(RR-13):1-25.
72. Alimonos K, Nafziger AN, Murray J, Bertino J. Prediction of response to hepatitis B vaccine in health care workers: Whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness. Clin Infect Dis 1998;26:566-71. 
73. Davis GL. Hepatitis C virus infection among health care workers. JAMA 1996;275:1474. 
74. Sepkowitz KA. Occupationally acquired infections in health care workers. Part II. Ann Intern Med 1996;125:917-28.

REGRESAR AL ARTÍCULO

Regresar